|
|
 |
|
HIV, cholesterol treatments under fire San Francisco Chronicle The U.S. Food and Drug Administration has ordered Foster City's Gilead Sciences Inc. and drug giant Bristol-Myers Squibb to pull the plug on what it called false marketing messages. The FDA warned Gilead for the second time in just over a year that its sales representatives were downplaying the risks and exaggerating the benefits of its HIV drug, Viread.
—Posted: August 9, 2003
More news headlines: This week | Last week | Search archive
|
|
|
